ArticleBlood advances2021

Adoptive therapy with CMV-specific cytotoxic T lymphocytes depends on baseline CD4+ immunity to mediate durable responses.

Vanessa A Fabrizio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.